Pancreatic cancer and thromboprophylaxis

Research activity is centered on advanced pancreatic cancer with a specific focus on preventing venous thromboembolism during active anticancer treatment. The clinical interest includes the relationship between VTE prevention and progression-free survival in patients with locally advanced or metastatic disease.

• Advanced pancreatic cancer
• Venous thromboembolism prevention
• Progression-free survival
• Anticancer treatment support

The sponsor’s research interest extends to the use of tinzaparin alongside first-line chemotherapy in the setting of pancreatic malignancy, reflecting a therapeutic emphasis on reducing thrombotic complications in oncology care.